alpha-MSH is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Last reviewed on 2025-10-12. Where a claim depends on a specific study, the study is described rather than over-claimed.
Scientific discussion of Melanotan-2 spans pharmacology, dermatology, and public-health literature. Laboratory studies examine its receptor binding and cellular effects, while clinical reports describe outcomes observed after unregulated use. These two bodies of work differ in rigour and intent. Peer-reviewed trials of the compound as a medicine are limited, so much of the available information comes from case reports and surveillance data. Authors frequently note the gap between experimental findings and real-world use.
Reported observations after unregulated use include shifts in skin pigmentation and, in some accounts, unintended changes to moles and other lesions. Whether these outcomes are causally linked to the compound, and how often they occur, remain open questions because controlled data are scarce. The absence of standardised dosing and verified product purity complicates interpretation. Researchers have called for better surveillance and analytical characterisation of samples obtained outside regulated channels. Conclusions drawn from anecdotal evidence should be treated as provisional.
Melanotan-2 is a synthetic linear peptide built from seven amino acids arranged in a short chain. Its sequence is commonly written as Ac-Nle-Asp-His-D-Phe-Arg-Trp-Lys-NH2, which includes a modified N-terminus and an amidated C-terminus. The molecule belongs to the melanocortin family and acts as a receptor agonist. Structural features such as the D-phenylalanine residue and the Nle substitution are associated with increased stability against enzymatic degradation relative to the natural parent peptide.
The compound emerged from research programs in the 1980s that examined analogues of alpha-melanocyte-stimulating hormone for pigmentation and photoprotection. Investigators modified the native sequence to extend activity duration and potency. A related analogue, afamelanotide, was developed within the same broad line of inquiry and eventually gained approval in certain jurisdictions for a rare light-sensitivity condition. Melanotan-2 itself did not progress through the same regulatory route and has no approved therapeutic indication.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Unapproved for therapeutic use | No marketing authorisation from major agencies |
| Legal classification | Varies by jurisdiction | Prescription-only or controlled in several countries |
| Common synonyms | Melanotan II; MT-II | Also referenced by catalogue codes |
| Typical analytical method | Reverse-phase HPLC | Often paired with mass spectrometry |
| Primary literature focus | Receptor pharmacology | Pigmentation and melanocortin signalling |
Identity and purity are assessed with chromatographic and mass spectrometric techniques. Reversed-phase high-performance liquid chromatography separates the target peptide from related impurities and degradation products, and the resulting retention time is compared against a reference standard. Mass spectrometry, often coupled to liquid chromatography, confirms molecular mass. Amino acid analysis or peptide mapping can provide additional sequence-level confirmation when required. Results are only as reliable as the reference materials used alongside them.
Regulatory treatment varies by country. In the United States, melanotan-2 is not approved for any indication, and products marketed for human use fall outside the approved drug framework. Some other jurisdictions have placed it under prescription controls or listed it as a prohibited or restricted substance. Online listings frequently describe the material as a research chemical, a category that does not carry the same manufacturing and labelling requirements as approved medicines.
Solid peptide material is generally stable when kept cold and dry. Common practice is storage at -20 degrees Celsius or lower, with desiccant and protection from light. Repeated freeze-thaw cycles and exposure to moisture are associated with degradation, aggregation, or loss of material. Once dissolved, stability depends on solvent, concentration, and temperature, and solutions are usually treated as short-lived unless stability data support longer periods. Handling notes typically emphasise minimising time at ambient temperature.
Melanotan II is a synthetic cyclic heptapeptide analogue of alpha-melanocyte-stimulating hormone, a naturally occurring peptide involved in pigmentation signalling. Its structure substitutes a lactam bridge between side chains to increase stability relative to the native hormone. The compound is also known by the shorthand MT-II and by several non-proprietary synonyms used in research catalogues. It is not an approved therapeutic product in any major jurisdiction; material sold under this name is typically offered as a laboratory reagent rather than as a medicine.
Activity is attributed to agonism at melanocortin receptors, particularly MC1R and MC4R. Activation of MC1R on melanocytes increases melanin synthesis, which underlies the reported tanning effect. MC4R engagement in the central nervous system is linked to appetite suppression and to effects on sexual arousal reported in early clinical studies. Those studies were small and were not designed to establish efficacy or long-term safety. Receptor selectivity among the melanocortin subtypes is not absolute, which complicates attribution of any effect to a single pathway.
Regulatory treatment varies between countries. Several national medicines agencies have classified the peptide as unapproved, and customs authorities in some jurisdictions seize shipments on that basis. A few jurisdictions channel supply through prescription-only frameworks that do not list the substance by name. Because the material circulates mainly through online vendors, composition and purity are rarely verified before sale. Surveys of unapproved peptide products have reported labels that did not match measured content in a substantial fraction of samples.
Lyophilised peptide powder is comparatively stable when kept dry, cold and protected from light. Once dissolved, the molecule is exposed to hydrolysis, oxidation and microbial growth, and degradation accelerates at higher temperatures and in alkaline solution. Repeated freeze-thaw cycles concentrate solutes and promote aggregation. Handling guidance for research peptides commonly clusters around freezer temperatures for powder and short refrigerated use for reconstituted solutions, with pH control and sterile technique applied throughout.
Verification of a purchased sample requires documentation linking a batch to a certificate of analysis, and that document should be read for the methods used rather than the headline purity figure. A single chromatographic percentage does not establish identity. Independent laboratories can perform identity and content assays, but no such test establishes that a product is suitable for human use. Claims about efficacy rest largely on small, early studies rather than on replicated controlled trials, and that gap remains open.
Identity testing for a cyclic peptide of this size usually relies on reversed-phase high-performance liquid chromatography coupled to mass spectrometry. The mass spectrum confirms molecular weight, while the chromatographic trace indicates the proportion of related impurities. Tandem mass spectrometry can provide sequence-level information when fragmentation data are compared against a reference standard. Nuclear magnetic resonance is sometimes used to confirm the lactam bridge, although it requires more material and greater operator expertise than routine chromatographic methods.
Thus, the two substrates of this enzyme are D-galactose (shown in its aldehydo form) and oxidised nicotinamide adenine dinucleotide phosphate (NADP+). Its products are D-galactono-1,5-lactone, reduced NADPH, and a proton. This enzyme belongs to the family of oxidoreductases, specifically those acting on the CH-OH group of donor with NAD+ or NADP+ as acceptor. The systematic name of this enzyme class is D-galactose:NADP+ 1-oxidoreductase. Other names in common use include D-galactose dehydrogenase (NADP+), and galactose 1-dehydrogenase (NADP+). This enzyme participates in galactose metabolism.
There are a multitude of methods to detect them. Each of the approaches has its own strengths and weaknesses, especially with regard to the sensitivity and specificity of the method. The most conventional and widely used high-throughput methods are yeast two-hybrid screening and affinity purification coupled to mass spectrometry.
The hydrophobic effect represents the tendency of water to exclude non-polar molecules. The effect originates from the disruption of highly dynamic hydrogen bonds between molecules of liquid water. Polar chemical groups, such as OH group in methanol do not cause the hydrophobic effect. However, a pure hydrocarbon molecule, for example hexane, cannot accept or donate hydrogen bonds to water. Introduction of hexane into water causes disruption of the hydrogen bonding network between water molecules. The hydrogen bonds are partially reconstructed by building a water "cage" around the hexane molecule, similar to that in clathrate hydrates formed at lower temperatures. The mobility of water molecules in the "cage" (or solvation shell) is strongly restricted. This leads to significant losses in translational and rotational entropy of water molecules and makes the process unfavorable in terms of free energy of the system. In terms of thermodynamics, the hydrophobic effect is the free energy change of water surrounding a solute. A positive free energy change of the surrounding solvent indicates hydrophobicity, whereas a negative free energy change implies hydrophilicity. In this way, the hydrophobic effect not only can be localized but also decomposed into enthalpic and entropic contributions.
Sources: en.wikipedia.org
=== Writing career === After writing several short stories, a novella and book reviews, his debut crime novel, Dead I Well May Be, was published by Scribner in 2003. The book was followed by two sequels in what would become to be known as the Michael Forsythe Trilogy. Alongside these, McKinty wrote the three books in his Lighthouse Trilogy, a series of science fiction young adult novels set in New York City, his native Ireland, and the fictional planet Altair. In 2008 McKinty moved with his family to Melbourne, Australia, to become a full-time writer. He found his greatest success and critical acclaim with the Sean Duffy series, following the eponymous Royal Ulster Constabulary Sergeant during The Troubles, beginning with 2012's The Cold Cold Ground. In 2019, the author made this comment about that novel: "It didn't sell very well, but it ended up getting the best reviews of my career. I got shortlisted for an Edgar, won a couple of awards, and so then that set me on that path for the next six years of reluctantly, kind of being dragged into writing about Northern Ireland in the 1980s". The third Duffy book, In the Morning I'll Be Gone, won the 2014 Ned Kelly Award for Best Novel. McKinty has been an especially astute observer of class in fiction. He also began working as a writer and reviewer for a number of publications including The Guardian, The Sydney Morning Herald, The Washington Post, The Independent, The Australian, The Irish Times and Harpers.
In the United States, dog foods labelled as "complete and balanced" must meet standards established by the Association of American Feed Control Officials (AAFCO), either by meeting a nutrient profile or by passing a feeding trial. The Dog Food Nutrient Profiles were last updated in 2016 by the AAFCO's Canine Nutrition Expert Subcommittee. Critics argue that due to the limitations of the trial and the gaps in knowledge within animal nutrition science, the term "complete and balanced" is inaccurate and even deceptive. An AAFCO panel expert has stated that "although the AAFCO profiles are better than nothing, they provide false securities." Certain manufacturers label their products with terms such as "premium", "ultra premium", "natural", and "holistic". Such terms currently have no legal definitions and are not regulated. There are also varieties of dog food labeled as "human-grade food." Although no official definition of this term exists, the assumption is that other brands use foods that would not pass US Food and Drug Administration inspection according to the Pure Food and Drug Act or the Meat Inspection Act. The ingredients on the label must be listed in descending order by weight before cooking. This means before all of the moisture is removed from the meat, fruits, vegetables and other ingredients used.
The battle at Qalabane demoralized the Cape Mounted Yeomanry, which had previously successfully repulsed much larger bodies of enemy troops, but the Basuto hailed the clash as a great victory. Clarke reached Mafeteng, engaging in counter-insurgency operations in its vicinity until the end of the month before returning to the Cape.
signal peptide Also leader peptide, prepeptide, and presequence. Any sequence of amino acids, usually 15–30 residues in length, that functions as a molecular signal directing the sorting and transport of the polypeptide bearing it to a specific location within a cell or organelle. Signal peptides are commonly located close to either the N-terminal or C-terminal ends of nascent or recently synthesized polypeptides, especially those destined for secretion from the cell or integration into a membrane, and are typically cleaved off by a dedicated signal peptidase when their polypeptide reaches the endoplasmic reticulum. Similar but distinct varieties of protein targeting are accomplished with nuclear localization signals and post-translational protein tags.
Sources: en.wikipedia.org
=== 20 July === Russia claimed to have taken the villages of Pishchane in Kharkiv Oblast and Andriivka in Luhansk Oblast. Two people were killed in a Russian aistrike in Barvinkove, Kharkiv Oblast. In Russia, the governor of Rostov Oblast, Vasily Golubev, reported that 26 Ukrainian drones were shot down overnight with no casualties. Sixteen explosions were also reported near Millerovo air base, during which fires were reported near the base's runway, airport apron and an oil depot.
Susan Weintraub is an American scientist. She is a professor at the University of Texas Health Science Center at San Antonio (UTHSCSA). She received a BS in chemistry from the University of Pennsylvania in 1967, MS in chemistry from Trinity University in 1970 and a PhD in biochemistry from UTHSCSA in 1979. She was the president of the American Society for Mass Spectrometry for the period of 2012-2014. In 2017 she was named a Fellow of the American Association for the Advancement of Science (AAAS), and Fellow of the American Society for Mass Spectrometry in 2025. She is an associate editor of the Journal of Proteome Research. Her research focuses on biomedical mass spectrometry where she used mass spectrometry in the early 1970s for quantitative analysis of brain neurochemicals. She has been director of the mass spectrometry core resource at UTHSCSA since 1979.
An ACS program chair, Gopal Coimbatore, said that without a proper forum the matter would never be discussed and, "with the world facing an energy crisis, it is worth exploring all possibilities." On 22–25 March 2009, the American Chemical Society meeting included a four-day symposium in conjunction with the 20th anniversary of the announcement of cold fusion. Researchers working at the U.S. Navy's Space and Naval Warfare Systems Center (SPAWAR) reported detection of energetic neutrons using a heavy water electrolysis setup and a CR-39 detector, a result previously published in Naturwissenschaften. The authors claim that these neutrons are indicative of nuclear reactions. Without quantitative analysis of the number, energy, and timing of the neutrons and exclusion of other potential sources, this interpretation is unlikely to find acceptance by the wider scientific community.
Sources: en.wikipedia.org
Major regulatory agencies have not approved it for any indication. Some countries permit it only under prescription frameworks, while others classify it as a controlled substance.
Much of the evidence comes from case reports and accounts of unregulated use rather than controlled trials. Differences in product purity and dosing add further variability.
Laboratory work focuses on receptor binding and cellular signalling. Observational reports document outcomes after use, and analytical chemists examine samples to assess content and purity.
No. Melanotan-2 is manufactured synthetically. The naturally occurring peptide in the same family is alpha-melanocyte-stimulating hormone, which the body produces as part of normal endocrine and neural signalling.